MICHAEL VOLK to Hepatitis C
This is a "connection" page, showing publications MICHAEL VOLK has written about Hepatitis C.
Connection Strength
1.271
-
The "PHS Increased Risk" Label Is Associated With Nonutilization of Hundreds of Organs per Year. Transplantation. 2017 07; 101(7):1666-1669.
Score: 0.403
-
The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ Transplantation. Am J Transplant. 2017 Nov; 17(11):2790-2802.
Score: 0.403
-
Public health impact of antiviral therapy for hepatitis C in the United States. Hepatology. 2009 Dec; 50(6):1750-5.
Score: 0.238
-
Direct-Acting Antiviral Therapy for Hepatitis C Virus Infection Is Associated With Increased Survival in Patients With a History of Hepatocellular Carcinoma. Gastroenterology. 2019 11; 157(5):1253-1263.e2.
Score: 0.116
-
Transplantation of hepatitis C virus (HCV) antibody positive, nucleic acid test negative donor kidneys to HCV negative patients frequently results in seroconversion but not HCV viremia. Am J Transplant. 2018 10; 18(10):2451-2456.
Score: 0.109